Blue Trust’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
Blue Trust's GMAB Position: Q3 2026 in Review
Blue Trust reduced its Genmab (GMAB) stake by 47% in Q3 2026, selling an estimated $175K and leaving 6,140 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #720.
Blue Trust first reported a position in GMAB in Q2 2022 and has held it in 18 quarters since. The position peaked at $377K in Q3 2025. 261 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Blue Trust held 6,140 shares of Genmab worth $219K as of Q3 2026.
- Blue Trust sold 5,536 Genmab shares in Q3 2026, an estimated $175K.
- Genmab made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #720 holding.
- Blue Trust first reported a position in Genmab in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Genmab position peaked at $377K in Q3 2025.
- 261 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.